ABBOTT'S DRUG-COATED STENT PASSES TEST

While Abbott Laboratories is nearing completion of an acquisition that will make the company a first-tier player in the business of unclogging arteries to the heart, the North Chicago drug and medical products giant this week made progress on its own stent. The Chicago Tribune (http://www.chicagotribune.com/business/chi-0603160304mar16,1,1640384.story?coll=chi-business-hed)